Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
Journal of Magnetic Resonance Imaging,  Clinical Article

Chang YC et al. – Dynamic contrast–enhanced (DCE) magnetic resonance imaging (MRI) enables a functional analysis of the treatment response of nonsmall–cell lung cancer (NSCLC). MRI parametric histogram has the potential to predict early treatment response of combined bevacizumab, gemcitabine, and cisplatin.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Radiology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Radiology Articles

Indexed Journals in Radiology: Clinical Radiology, American Journal of Roengenology, Academic Radiologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close